PEMETREXED 100 mg/10mL (Pemetrexed INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 100 mg/10mL

Pemetrexed 100 mg/10mL is a lyophilized powder for solution, used in intravenous therapy. This medication is commonly associated with certain cancer treatments. Learn more about its uses and effects.

Strength

100 mg/10mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0338-0720-01) / 10 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Baxter Healthcare Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pemetrexed is primarily used in the treatment of specific types of cancer. It is often administered intravenously as part of a broader treatment plan. The medication works by interfering with the growth and spread of cancer cells. Patients should consult their healthcare provider to understand what Pemetrexed is used for in their specific case.

Side Effects

Common effects of Pemetrexed may include fatigue, nausea, and low blood cell counts. Some patients may experience more severe side effects, which should be discussed with a healthcare professional. It is important to monitor for any unusual symptoms while undergoing treatment with Pemetrexed.

Precautions & Warnings

Pemetrexed should be handled with care, as it is a potent medication. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their doctor about any existing medical conditions or allergies before starting treatment.

Avoid Interactions

Pemetrexed may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other cancer treatments. It is crucial to disclose all current medications to a healthcare provider to avoid potential interactions. Alcohol consumption should also be discussed with a doctor.

Frequently Asked Questions

Pemetrexed is used in the treatment of specific types of cancer, often as part of a broader treatment plan.

Pemetrexed is administered intravenously as a lyophilized powder for solution.

Common side effects may include fatigue, nausea, and low blood cell counts.

Yes, Pemetrexed may interact with NSAIDs and other cancer treatments, so it's important to consult a healthcare provider.

Patients should follow prescribed dosage instructions and inform their doctor about any existing medical conditions or allergies.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.